NDC 72266-163-01 - Tobramycin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72266-163
- Requested NDC
- 72266-163-01
- Package NDCs from labels
- 72266-163-01, 72266-163-06
- Manufacturer
- Fosun Pharma USA Inc
- Effective date
- 2024-07-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Tobramycin - Fosun Pharma USA Inc | Fosun Pharma USA Inc | 2024-07-02 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72266-163-01 | Tobramycin | 30 mL in 1 VIAL, PHARMACY BULK PACKAGE | INJECTION, POWDER, LYOPHILIZED, | 30 | 3 | |
| 72266-163-06 | Tobramycin | 6 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 6 | 3 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72266-163-01 | EA - Each | 72266-163 | aa2e13c0-f672-46f0-9998-66a5b05280a9 | 1 | 2021-09-07 |
| 72266-163-06 | EA - Each | 72266-163 | cd53756c-fed9-441a-8287-c308f8970026 | 1 | 2021-09-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TOBRAMYCIN | TOBRAMYCIN | Hospira, Inc. | c5a005b0-7b6f-4e30-df92-9a20b1ca66a1 | 2026-04-13 | Boxed warning, Warnings, Adverse reactions | 597823 HJT0RXD7JK |
| Tobramycin | TOBRAMYCIN | Xiromed LLC | 8b50d1b5-ea8a-5844-358a-493f1965c07f | 2026-02-23 | Boxed warning, Warnings, Adverse reactions | ANDA211189 597823 HJT0RXD7JK |
| tobramycin | TOBRAMYCIN | Slate Run Pharmaceuticals, LLC | ed254eec-10f4-425a-895b-66e325b7bf69 | 2026-02-10 | Boxed warning, Warnings, Adverse reactions | 597823 |
| Tobramycin | TOBRAMYCIN | XGen Pharmaceuticals DJB, Inc. | a384641c-04e3-4ab5-b152-7408cd07b64d | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | 597823 HJT0RXD7JK |
| Tobramycin | TOBRAMYCIN | Northstar Rx LLC | 55d09ffd-4f32-8aeb-3904-8a17db635e3a | 2025-09-23 | Boxed warning, Warnings, Adverse reactions | ANDA211189 597823 HJT0RXD7JK |
| TOBRAMYCIN | TOBRAMYCIN | Eugia US LLC | c37c251f-92e9-40f0-8b0c-00d42875d776 | 2024-07-06 | Boxed warning, Warnings, Adverse reactions | 597823 HJT0RXD7JK |
| Tobramycin | TOBRAMYCIN SULFATE | Fresenius Kabi USA, LLC | 9a5cecd6-aa65-42d2-b15a-06b4fcebcc0f | 2024-02-07 | Boxed warning, Warnings, Adverse reactions | 597823 HJT0RXD7JK |
| Tobramycin | TOBRAMYCIN SULFATE | Fresenius Kabi USA, LLC | d6dd9460-b030-479a-b3e3-03606e6fcad1 | 2024-02-05 | Boxed warning, Warnings, Adverse reactions | 597823 HJT0RXD7JK |
| Tobramycin | TOBRAMYCIN SULFATE | Fresenius Kabi USA, LLC | d62ff359-912b-4be1-9fc2-2dde8777eefb | 2024-01-15 | Boxed warning, Warnings, Adverse reactions | 597823 HJT0RXD7JK |
| Tobramycin | TOBRAMYCIN | Baxter Healthcare Corporation | a9897444-71f6-42af-9b71-4aa77829ade0 | 2023-03-15 | Boxed warning, Warnings, Adverse reactions | 597823 HJT0RXD7JK |
| Tobramycin | TOBRAMYCIN | Gland Pharma Limited | 645d34d9-275d-428e-863d-ae15ad009c44 | 2023-03-09 | Boxed warning, Warnings, Adverse reactions | 597823 HJT0RXD7JK |
| Tobramycin | TOBRAMYCIN | Gland Pharma Limited | 02b48684-168c-4cd9-8375-794206eff23e | 2023-02-27 | Boxed warning, Warnings, Adverse reactions | 597823 HJT0RXD7JK |
| Tobramycin | TOBRAMYCIN | Fosun Pharma USA Inc | c4751a4f-c9c1-60c5-e053-2995a90aeba9 | 2022-12-02 | Boxed warning, Warnings, Adverse reactions | ANDA211189 72266-163-06 72266-163-01 72266-163 72266016301 597823 55a28671-9f6d-90be-e063-6294a90ac87c c4751a4f-c9c1-60c5-e053-2995a90aeba9 HJT0RXD7JK |
| Tobramycin | TOBRAMYCIN | Mylan Institutional LLC | ac8134d9-a726-4508-b8b9-a536ef17243d | 2022-10-31 | Boxed warning, Warnings, Adverse reactions | 597823 HJT0RXD7JK |
| Tobramycin | TOBRAMYCIN | Gland Pharma Limited | 38219f34-4859-428f-9ec1-06ead7604211 | 2022-10-17 | Boxed warning, Warnings, Adverse reactions | ANDA211189 597823 HJT0RXD7JK |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.